The aims of this study were to use two-sample MR to explore whether: (i) the causal effect of chronotype on breast cancer risk found previously [10] remains consistent using newly available breast cancer data, including data on subtypes [32]; (ii) chronotype exerts a causal effect on prostate cancer risk; and (iii) the effect of chronotype on breast, and any effect on prostate cancer risk, is mediated or confounded by sex hormones (total testosterone, bioavailable testosterone, sex hormone binding globulin (SHBG) and oestradiol). The gene discussed is SHBG; the disease is breast carcinoma.